Prevalence and the associated factors of hepatitis B and hepatitis C viral infections among HIV-positive individuals in same-day antiretroviral therapy initiation program in Bangkok, Thailand

Thitipatarakorn, Supanat; Chinbunchorn, Tanat; Peelay, Jitsupa; Seekaew, Pich; Amatavete, Sorawit; Sangsai, Monsiri; Pankam, Tippawan; Avihingsanon, Anchalee; Avery, Matthew; Phanuphak, Praphan; Ramautarsing, Reshmie; Phanuphak, Nittaya

doi:10.1186/s12889-021-12429-6

Cited by 7 publications

(5 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This finding explains why this study's monitoring/evaluation of HIV/AIDs prevention programmes suggested a high extent. The findings, however, contradict other studies that documented that the rising frequency of sexually transmitted illnesses, especially HIV/AIDS, demonstrates that previous attempts to combat the pandemic have been insufficient, even with antiretroviral therapy (Kalichman, Eaton, and Kalichman 2021;Mosha et al 2022;Jing et al 2022;Thitipatarakorn et al 2022). The disparity in results might be related to variations in the factors included in the investigations.…”

Section: Discussion Of Findingscontrasting

confidence: 83%

Care/Support, Location, and the Monitoring/Evaluation of HIV/AIDs Prevention Programs: The Case of Southern Senatorial District of Cross River State, Nigeria

Akah¹,

Ekpo²,

Owan³

2022

The International Journal of Interdisciplinary Educational Stud

View full text Add to dashboard Cite

This study analysed the monitoring and evaluation of HIV/AIDS prevention programmes in the Southern Senatorial District of Cross River State, Nigeria. The study considered different levels of care/support and tested for locational variations in the monitoring/evaluation of HIV/AIDs prevention programmes. A descriptive survey design was utilised. This study covered 596 public health employees (doctors, nurses, pharmacists, and laboratory employees) in the study area. Using the proportional stratified random sampling procedure, a sample of 239 respondents was chosen. Data was collected using a questionnaire constructed by the researchers and validated by specialists. Data gathered were analysed using descriptive and inferential statistics. Results indicated that HIV/AIDs programmes had been successfully monitored/evaluated to a high extent. High success rates in the monitoring/evaluation of HIV/AIDs prevention programmes are attributable to high rates of care/support provided to people living with HIV/AIDs. There was a significant variation in the monitoring/evaluation of HIV/AIDs prevention programmes based on the location of health facilities, with higher rates recorded for urban areas. Based on the findings, it was concluded that the monitoring/evaluation of HIV/AIDs prevention programmes in the Southern Senatorial District of Cross River State had recorded a significant level of success. The study recommended, among others, that there should be even distribution of medical facilities, resources and personnel to both urban and rural areas to promote equity and access to materials needed to contain or mitigate the spread of the pandemic across all locations.

show abstract

Section: Discussion Of Findingscontrasting

confidence: 83%

Care/Support, Location, and the Monitoring/Evaluation of HIV/AIDs Prevention Programs: The Case of Southern Senatorial District of Cross River State, Nigeria

Akah¹,

Ekpo²,

Owan³

2022

The International Journal of Interdisciplinary Educational Stud

View full text Add to dashboard Cite

show abstract

“…Anti-HCV positivity was found in 4-5% of PWH who were MSM and TGW. As World Health Organization and Thailand national guidelines already support routine screening of hepatitis B and C viral infections in PWH and populations at increased risk of HIV including MSM and TGW, healthcare providers should reinforce this strategy [2]. These findings were higher than the present study, which can be due to differences in viral hepatitis risk factors, different cultures and sample size.…”

Section: Discussioncontrasting

confidence: 79%

“…The name of this new disease was AIDS. More than 70 million people have been infected with HIV [2]. Ninety percent of HIV infections are in developing countries and Eighty percent are sexual transmission from men who have sex with men (MSM).…”

Section: Introductionmentioning

confidence: 99%

Prevalence of hepatitis B in HIV-positive patients in Zabol

Rezaie-Kahkhaie

Saravani

Keikhaie

et al. 2021

Cell. Mol. Biomed. Rep.

View full text Add to dashboard Cite

Today, due to the increase in life expectancy in HIV-infected patients, the incidence of related diseases such as hepatitis B and C due to similarity in transmission routes has become a major concern of the health community. Therefore, this study was performed to determine the prevalence of hepatitis B among HIV + patients in Zabol. This descriptive cross-sectional study was performed on 37 HIV-infected patients in Zabol city (2021)(2022). In the present study, HIV-infected patients were screened for hepatitis B by measuring serum levels of HBC Ab and HBs Ag. Finally, the data in SPSS V21 software were analyzed. In the present study, a total of 37 HIV-infected patients with a mean age of 40.81-11.64 years were evaluated. The present study's prevalence of HIV and HCV coinfection was 21.6%. Also, 13.5% of HIV patients had HBV and HCV simultaneously. Examination of risk factors for viral hepatitis in HIVinfected patients showed that unprotected sex (100%), injecting drug use or IDU (87.5%), dental procedures (75%), history of imprisonment (62.5%) and tattooing (50.5%) were the most common factors in HIV patients. Family history of hepatitis B (12.5%), alcohol (12.5%), transfusion (12.5%) and cupping (25%) were among the lowest cases in these patients. the frequency of HBV infection and co-infection with HCV and HBV in HIV-positive patients were relatively high. Except for the history of tattoos, there is no significant relationship between other risk factors and hepatitis B among HIV-positive patients.

show abstract

“…Nonetheless, this prevalence is up to 6.9% in some provinces 3 . The prevalence of HCV co‐infection with human immunodeficiency virus (HIV) in Thailand is 4.1% 4 and as high as 77.6% in patients with HIV and history of intravenous drug usage 5 . HCV infection in HIV‐positive patients leads to aggressive liver diseases with advanced fibrosis and earlier progression to end‐stage liver diseases 6–8 .…”

Section: Introductionmentioning

confidence: 99%

Real‐world treatment outcomes of sofosbuvir‐based regimens for treatment of chronic hepatitis C with and without human immunodeficiency virus co‐infection

Khemnark

Manosuthi

2023

JGH Open

View full text Add to dashboard Cite

Background and Aim The efficacy of sofosbuvir (SOF)‐based regimens in the treatment of chronic hepatitis C (HCV) patients with and without human immunodeficiency virus (HIV) co‐infected patients in real‐world setting is limited. Methods This was a retrospective cohort study, conducted between 1 January 2017 and 31 December 2021 at Bamrasnaradura Infectious Disease Institute, Thailand. All HCV patients received 12 weeks of SOF‐based regimens and had follow‐up for at least 12 weeks after therapy discontinuation. The primary outcome was sustained virological response (SVR) at 12 weeks after the end of treatment. Treatment outcomes were compared between HCV patients with and without HIV co‐infection. Results A total of 163 patients were included in the study, 130 (79.8%) were HCV/HIV co‐infected, and 33 (20.2%) were HCV mono‐infected. Of all, 106 (64%) patients received SOF and ledipasvir. Genotype 1 (GT1) was predominant at 66.4%, followed by GT3 at 22.2%, and GT6 at 11.4%. Overall SVR was 96.9%. SVR in HCV mono‐infected was 96.9% and SVR in HIV‐HCV co‐infected patients was 96.9%. The factor associated with SVR was HCV genotype ( P = 0.001). Patients with HCV GT6 had lower SVR rates compared with GT1 and GT3 patients (83.3%, 100%, and 97.1% [ P = 0.000] respectively). There was no association between SVR and other factors such as gender, age, BMI, underlying cirrhosis, baseline HCV viral load, or prior treatment history (all P > 0.05). All patients completed 12‐week SOF‐based treatment. Conclusion In real‐world setting, HCV treatment with SOF‐based regimens between patients with and without HIV co‐infection showed high rates of SVR. SOF‐based regimens were highly efficacious and tolerated.

show abstract

Prevalence and the associated factors of hepatitis B and hepatitis C viral infections among HIV-positive individuals in same-day antiretroviral therapy initiation program in Bangkok, Thailand

Cited by 7 publications

References 37 publications

Care/Support, Location, and the Monitoring/Evaluation of HIV/AIDs Prevention Programs: The Case of Southern Senatorial District of Cross River State, Nigeria

Care/Support, Location, and the Monitoring/Evaluation of HIV/AIDs Prevention Programs: The Case of Southern Senatorial District of Cross River State, Nigeria

Prevalence of hepatitis B in HIV-positive patients in Zabol

Real‐world treatment outcomes of sofosbuvir‐based regimens for treatment of chronic hepatitis C with and without human immunodeficiency virus co‐infection

Contact Info

Product

Resources

About